Löffler H, Gassmann W
2nd Department of Internal Medicine, Christian-Albrechts-Universität Kiel, Germany.
Baillieres Clin Haematol. 1994 Jun;7(2):263-72. doi: 10.1016/s0950-3536(05)80202-1.
ALL is characterized by small to medium sized leukaemic blasts with a rather low grade of cell-to-cell variability. The nucleocytoplasmic ratio is high with just a small cytoplasmic rim in many cases. The cytoplasm tends to be moderately basophilic. Usually, though not in each instance, it is agranular and free of vacuoles. The chromatin is more condensed than in AML and the nucleoli tend to be indistinct. The FAB classification of haematological malignancies separates ALL into three categories: ALL L1, L2, and L3. However, just the identification of the L3 variant is of major importance. The L3 cells are medium sized to large and are characterized by intensely basophilic and moderately abundant cytoplasm with prominent cytoplasmic vacuolation in the bone marrow but not necessarily in the peripheral blood. According to our experience there is a high but not universal correlation of the L3 phenotype as defined by morphology with the immunologically defined B-ALL with surface expression of immunoglobulins. Until recently, acute leukaemias proving negative for all cytochemical tests especially for the PAS reaction and for the focal type of acid phosphatase, were termed 'acute undifferentiated leukaemia' (AUL). However, this morphological/cytochemical diagnosis may be confused with the immunological diagnosis of unclassifiable leukaemia. Since almost any of these cases can be recognized as ALL or AML by immunology, the term AUL should be reserved for cases which can be classified neither by morphology/cytochemistry nor by immunology. The morphological and cytochemical distinction of ALL from poorly differentiated AML remains a problem, especially if the FAB criteria for distinguishing ALL from AML by cytochemistry (3% of the blasts positive for peroxidase) are applied rigidly. A small but significant percentage of poorly differentiated leukaemias have less than 3% of the blasts positive for peroxidase and the myeloid nature of the leukaemia can be identified by cytochemistry. The absence of blasts being positive for peroxidase is no reliable indicator for the lymphatic nature of a leukaemia, even if the PAS reaction is typical for ALL. The morphological diagnosis of ALL needs confirmation by immunology in each instance.
急性淋巴细胞白血病的特征是白血病原始细胞大小从中等至小,细胞间变异性较低。核质比高,在许多情况下只有一小圈细胞质边缘。细胞质倾向于中度嗜碱性。通常,虽然并非在每种情况下,细胞质无颗粒且无空泡。染色质比急性髓系白血病更浓缩,核仁往往不明显。血液系统恶性肿瘤的FAB分类将急性淋巴细胞白血病分为三类:急性淋巴细胞白血病L1、L2和L3。然而,仅L3变异型的识别具有重要意义。L3细胞大小从中等至大,其特征是细胞质强烈嗜碱性且中等丰富,骨髓中有明显的细胞质空泡形成,但外周血中不一定有。根据我们的经验,形态学定义的L3表型与免疫定义的具有免疫球蛋白表面表达的B-急性淋巴细胞白血病之间存在高度但并非普遍的相关性。直到最近,所有细胞化学试验尤其是PAS反应和局灶性酸性磷酸酶试验均为阴性的急性白血病,被称为“急性未分化白血病”(AUL)。然而,这种形态学/细胞化学诊断可能与无法分类的白血病的免疫诊断相混淆。由于几乎所有这些病例通过免疫学都可被识别为急性淋巴细胞白血病或急性髓系白血病,因此AUL一词应保留用于既不能通过形态学/细胞化学也不能通过免疫学分类的病例。急性淋巴细胞白血病与低分化急性髓系白血病的形态学和细胞化学区分仍然是一个问题,特别是如果严格应用细胞化学区分急性淋巴细胞白血病与急性髓系白血病的FAB标准(3%的原始细胞过氧化物酶阳性)。一小部分但相当比例的低分化白血病原始细胞过氧化物酶阳性率低于3%,白血病的髓系性质可通过细胞化学鉴定。即使PAS反应是急性淋巴细胞白血病的典型表现,原始细胞过氧化物酶阴性也不是白血病淋巴系性质的可靠指标。急性淋巴细胞白血病的形态学诊断在每种情况下都需要免疫学确认。